Michael J. Fox Foundation donates Grifols $21 million to research new diagnostic tools for Parkinson’s disease
Link Securities | The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson’s Disease Research to identify plasma-based biomarkers that could indicate a person’s likelihood of developing Parkinson’s disease (PD) “many years before” clinical diagnosis. The initiative, dubbed ‘Chronos PD’, could accelerate the discovery of new diagnostic tools, as well as the identification and development of novel therapies that modify…









